MedPath
NMPA Approval

Dabigatran Etexilate Capsules

国药准字HJ20240154

December 1, 2024

Drug Information

达比加群酯胶囊

胶囊剂

75mg(以达比加群酯计)

化学药品

December 1, 2024

November 30, 2029

Company Information

Applicant Company

Unit-III, 22-110, I.D.A, Jeedimetla(V), Quthbullapur(M), Medchal-Malkajgiri(Dist.), 500 055, Telangana State, India

Manufacturing Company

Unit-III, 22-110, I.D.A, Jeedimetla(V), Quthbullapur(M), Medchal-Malkajgiri(Dist.), 500 055, Telangana State, India

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达比加群酯胶囊 - NMPA 批准文号 | MedPath